Modulators of 14-3-3 Protein–Protein Interactions
Year: 2017
Type: review
Abstract: Direct interactions between proteins are essential for the regulation of their functions in biological pathways. Targeting the complex network of protein-protein interactions (PPIs) has now been widely recognized as an attractive means to therapeutically intervene in disease states. Even though this is a challenging endeavor and PPIs have long been regarded as "undruggable" targets, the last two decades have seen an increasing number of successful examples of PPI modulators, resulting in growing interest in this field. PPI modulation requires novel approaches and the integrated efforts of multiple disciplines to be a fruitful strategy. This perspective focuses on the hub-protein 14-3-3, which has several hundred identified protein interaction partners, and is therefore involved in a wide range of cellular processes and diseases. Here, we aim to provide an integrated overview of the approaches explored for the modulation of 14-3-3 PPIs and review the examples resulting from these efforts in both inhibiting and stabilizing specific 14-3-3 protein complexes by small molecules, peptide mimetics, and natural products.
Source: Journal of Medicinal Chemistry
Institutions: Eindhoven University of Technology, University of Siena, University of Dundee, Charles University, Centre National de la Recherche Scientifique, Université de Lille, Unité de Glycobiologie Structurale et Fonctionnelle, University of Leeds, Lead Discovery Center (Germany), UCB Pharma (United Kingdom), GlaxoSmithKline (United Kingdom), AstraZeneca (Sweden), University of Duisburg-Essen
Language: English
Topic: 14-3-3 protein interactions
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,500
OpenAlex ID: W2763148184
